Daten zu öffentlichen Aufträgen und Fördermitteln in Europa aus amtlichen Registern · Datenstand: 17. November 2026, tägliche Aktualisierung.

Förderprogramm · Vereinigte Staaten

Aging Research

Aging Research (Vereinigte Staaten): Aufrufe und Förderungen des Programms. 116 Aufrufe auf der Seite, davon 32 offen; Aufrufe starten meist im August. Datenstand: 17. November 2026, tägliche Aktualisierung.

Fördergeber: National Institutes of Health (Department of Health and Human Services)

Förderungen der letzten 24 Monate
0
Empfänger
0
Offene Aufrufe
32
Aufrufe auf der Seite
116

Aufrufe starten meist im August

Über das Programm

Objectives: To encourage biomedical, social, and behavioral research and research training directed toward greater understanding of the aging process and the diseases, special problems, and needs of people as they age. The National Institute on Aging has established programs to pursue these goals.…

Mehr in der Quelle

Offene Aufrufe

FörderaufrufStatusFrist
NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25 Independent Clinical Trial Not Allowed) (Runde 09.2025 – 05.2027)Offen26. Mai 2027
NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independent Clinical Trial Not Allowed) (Runde 09.2025 – 05.2027)Offen26. Mai 2027
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) (Runde 12.2024 – 11.2027)Offen5. November 2027
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) (Runde 11.2024 – 11.2027)Offen12. November 2027
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)Offen7. Mai 2028
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)Offen12. Juni 2028
Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)Offen10. Oktober 2028
Dementia Care and Caregiver Support Intervention Research - Stages II - VGeplant—
Improving Chronic Conditions Through Inexpensive InterventionsGeplant—
The NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS)Geplant—
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)Geplant—
Claude D. Pepper Older Americans Independence CentersGeplant—
Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)Geplant—
Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)Geplant—
Biomarkers of Cognitive Decline and Dementias of Aging in Individuals within the Autism SpectrumGeplant—
Novel Approaches to Advance Precision Aging and Cognitive HealthGeplant—
Illuminating AD/ADRD Genome to Enable Precision Genomic MedicineGeplant—
Mechanisms Underlying Olfactory Dysfunction in Aging and Alzheimer’s Disease and Alzheimer’s Disease-Related DementiasGeplant—
Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs)Geplant—
Controlled Clinical Trials on Long-Term Effects of Nutritional Interventions on the Progression of Risk Factors for Age-Related Chronic Conditions Over the Life Span and Their Age of OnsetGeplant—
Alzheimer's Clinical Trials Consortium (ACTC) Clinical TrialsGeplant—
Understanding Cerebellar Contributions to Cognitive and Affective Functions in Aging and Alzheimer's Disease/Alzheimer's Disease-Related DementiasGeplant—
Dementia Care and Caregiver Support Intervention Research - Stage I OnlyGeplant—
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)Geplant—
Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)Geplant—
Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive DeclineGeplant—
Renewal of NIA Research Centers Collaborative Network (RCCN)Geplant—
Research Project Cooperative Agreements in Aging and/or Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) ResearchGeplant—
Specialized Center Cooperative Agreements in Aging and/or Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) ResearchGeplant—
Interdisciplinary Research to Understand the Complex Biology of Resilience to Alzheimer’s and Related Dementias Disease RiskGeplant—

Förderkalender

Förderungen für Projekte mit Beginn zwischen 17. November 2024 und 17. November 2026; Beträge in Euro zum Eurostat-Kurs des jeweiligen Jahres.

Fragen und Antworten

Aging Research: Wann starten die Förderaufrufe?
Derzeit offen (32): NIA Expanding Research in AD/ADRD (ERA) Postbaccalaureate Research Education Program (R25… (26. Mai 2027), NIA Expanding Research in AD/ADRD (ERA) Summer Research Education Program (R25 Independen… (26. Mai 2027), Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) (5. November 2027), …. Aufrufe starten meist im August.